DPP4 and obesity due to melanocortin 4 receptor deficiency: To the best of our knowledge, our study seems to be the first report showing that a DPP-4 inhibitor may exert positive regulation on gut flora dysregulated during progression of glucose intolerance and obesity in an animal model.